AU Patent
AU2011293132C1 — Compositions and methods for targeted thermomodulation
Assigned to Sebacia Inc · Expires 2016-04-21 · 10y expired
What this patent protects
Provided are nanoparticles and formulations which are useful for cosmetic, diagnostic and therapeutic applications to mammals such as humans.
USPTO Abstract
Provided are nanoparticles and formulations which are useful for cosmetic, diagnostic and therapeutic applications to mammals such as humans.
Drugs covered by this patent
- Austedo (DEUTETRABENAZINE) · Teva
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.